The Hunt For Big Fish: How KDDF Is Helping Create Korean Deals

Major ADC Projects Underway

Korea Drug Development Fund CEO H. Samuel Muk talks to Scrip how the government agency has evolved to support the Korean biopharma industry’s R&D and business development activities, as well as what key new projects are underway.

H.Samuel Muk, President & CEO of KDDF
KDDF President & CEO H Samuel Muk: LegoChem-Amgen, Alteogen-Sandoz Deals Highlight KDDF Support • Source: KDDF

As Korean biopharma firms, particularly bioventures, are suffering from a sharp decline in financing and licensing deals, the role of the state-supported Korea Drug Development Fund (KDDF) is becoming increasingly crucial to assist their R&D and business development activities and help weather the tough environment.

The KDDF was created in 2011, modelled after overseas agencies such as the US National Institutes of Health. The Korean...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia